Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
Aleyda M San Hernandez, Chetana Singh, Danel J Valero, et al.
Cureus (2020)
Open Access | Times Cited: 24

Showing 24 citing articles:

Serotonin reduction in post-acute sequelae of viral infection
Andrea C. Wong, Ashwarya S. Devason, Iboro C. Umana, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4851-4867.e20
Open Access | Times Cited: 222
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma
Achilles Ntranos, Hye-Jin Park, Maureen Wentling, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 569-583
Open Access | Times Cited: 65
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 63
Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis
Junjie Jian, Jun Wei
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
A gut‐centric view of aging: Do intestinal epithelial cells contribute to age‐associated microbiota changes, inflammaging, and immunosenescence?
Leah S. Hohman, Lisa C. Osborne
Aging Cell (2022) Vol. 21, Iss. 9
Open Access | Times Cited: 38
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
Dorota Kujawa, Łukasz Łaczmański, Sławomir Budrewićz, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 13
The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis
Ana Maria Bugă, Vlad Pădureanu, Anca‐Lelia Riza, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1872-1872
Open Access | Times Cited: 11
Vortioxetine Ameliorates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in Mice via Activation of PI3K/Akt/CREB/BDNF cascade and Modulation of Serotonergic Pathway Signaling
Marwa S Shafiek, Radwa Y. Mekky, Noha N. Nassar, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176929-176929
Closed Access | Times Cited: 4
Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model
Helga Polyák, Zsolt Galla, Cecília Rajda, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 976-976
Open Access
Decoding multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access | Times Cited: 3
Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
Katarzyna Wiszniewska, M. B. Wilk, Małgorzata Wiszniewska, et al.
Sclerosis (2025) Vol. 3, Iss. 2, pp. 13-13
Open Access
The therapeutic potential of diet on immune-related diseases: based on the regulation on tryptophan metabolism
Junjie Lin, Dongxiao Sun‐Waterhouse, Chun Cui
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 31, pp. 8793-8811
Closed Access | Times Cited: 23
The association between multiple sclerosis and migraine: A meta-analysis
Mohammad Mohammadi, Samuel Berchi Kankam, Sadaf Salehi, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104954-104954
Closed Access | Times Cited: 9
Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases
Leon M. T. Dicks
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4431-4431
Open Access | Times Cited: 3
Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 51, pp. 102888-102888
Closed Access | Times Cited: 20
Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
Yan Wang, David Pleasure, Wenbin Deng, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 18
Effects of hippocampal damage on pain perception in a rat model of Alzheimer's disease induced by amyloid-β and ibotenic acid injection into the hippocampus
Masayoshi Hayashi, Chiho Kudo, Hiroshi Hanamoto, et al.
Physiology & Behavior (2024) Vol. 285, pp. 114652-114652
Closed Access | Times Cited: 2
From intestinal metabolites to the brain: Investigating the mysteries of Long COVID
Shan Liu, Ashwarya S. Devason, Maayan Levy
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1
Obsessive–compulsive symptoms and brain lesions compatible with multiple sclerosis
Katharina von Zedtwitz, Ludger Tebartz van Elst, Horst Urbach, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 281-286
Open Access | Times Cited: 1
T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients
Flora Reverchon, Colleen Guillard, Lucile Mollet, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2418-2418
Open Access | Times Cited: 4
The role of dopamine in the modulation of monocyte-induced Th17- and Th1-immune response in multiple sclerosis
Olga Belousova, Anna Lopatina, Mikhail Melnikov
International Immunopharmacology (2024) Vol. 137, pp. 112540-112540
Closed Access
From Multiple Sclerosis to Organ-Specific Autoimmune Disorders: Insights into the Molecular and Clinical Implications of Comorbidity
Mohammad Reza Zabihi, Alireza Zangooie, Mobin Piroozkhah, et al.
Molecular Neurobiology (2024)
Closed Access
Behavioral disorders in multiple sclerosis: a comprehensive review
K. A. Jellinger
Journal of Neural Transmission (2024)
Closed Access
Are 5HT7 Receptors Possible Target for Multiple Sclerosis?
Antony Justin, Deepthi Murugan, Meghana Basavaraj, et al.
Research Journal of Pharmacy and Technology (2023), pp. 1514-1520
Closed Access
Page 1

Scroll to top